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Background: Localized scleroderma en coup de sabre (LScs) is a form of localized scleroderma thought to
be an autoimmune disorder. Central nervous system involvement is not rare and neurological mani-
festations include seizures, focal neurological deﬁcits, headache and neuropsychiatric changes.
Methods: Patients attending the Neurology Clinic with the ﬁnal diagnosis of LScs with neurological
manifestations were identiﬁed and clinical and imagiological records reviewed.
Results: Five patients (0.024%) had LScs with neurological involvement, presenting with transient focal
neurologic deﬁcits, seizures, headache or migraine with aura. Neuroimaging studies conﬁrmed localized
skin depression and showed bone thinning, white matter lesions, brain calciﬁcations, sulcal effacement
and meningeal enhancement. Three patients experienced clinical improvement after im-
munosuppressive therapy, and in two of these patients neuroimaging ﬁndings also improved.
Conclusions: Recognizing typical dermatologic changes is keystone for the diagnosis of LScs with neu-
rological involvement. It is a diagnosis of exclusion and extensive etiological diagnostic evaluation should
be performed. Treatment options, including conservative follow-up or immunosuppressive therapy,
should be carefully considered.
& 2016 Elsevier B.V. All rights reserved.1. Introduction
Localized scleroderma is a rare chronic disorder of unknown
etiology, which presents with typical skin and underlying tissue
sclerosis, classically considered not to present extra-cutaneous
involvement (Takehara and Sato, 2005). Localized scleroderma en
coup de sabre (LScs) is a form of localized scleroderma, involving
the fronto-parietal area, with band-like sclerotic lesions with
atrophy, furrow of the skin and outer diploe thinning (Unterberger
et al., 2003). Recent reports conﬁrm that central nervous system
involvement is not rare, and presentations include epileptic sei-
zures, headache, focal neurological deﬁcits and neuropsychiatric
changes (Appenzeller et al., 2004; Amaral et al., 2013).2. Material and methods
During the period 2008–2013, 20,531 patients attended our.Neurology Clinic for a ﬁrst consultation. Diagnostic electronic da-
tabase was used to identify patients with the diagnosis of LScs and
5 patients with LSsc with neurological involvement were found
(0.024%). Clinical and imagiologic records were reviewed for data
collection. Details that might disclose the identity of the patients
were omitted. The study is in accordance to the local ethics
committee requirements for clinical research.3. Results
We present a brief case description of the 5 patients with LSsc
with neurological involvement, and dermatological and neuroi-
maging ﬁndings are illustrated in Fig. 1.
3.1. Case 1
60-Year old man with sudden-onset aphasia and right hemi-
paresis lasting for 15–20 min. He reported 3 similar episodes in the
previous 6 years. He had a localized atrophic skin area in the left
fronto-parietal area that had been unchanged for several years.
Brain magnetic resonance imaging (MRI) conﬁrmed subcutaneous
Fig. 1. A–C: dermatological changes of scleroderma en coup de sabre, with focal skin atrophy and hyperpigmentation and underlying bone depression (arrows; case 1, 3 and
5 respectively). D: Case 1, FLAIR image shows left hemispheric sulcal effacement and a hyperintense white matter lesion. E–F: Case 2, CT-scan (E) reveals left frontal sulci
effacement and a left subcortical hypodense lesion with calciﬁcations, and contrast-enhanced T1(F) demonstrates left frontal skin and bone atrophy, with underlying dural
enhancement and sulci effacement. G–H: Case 3, FLAIR (G) and contrast-enhanced T1 (H) depict hyperintense, contrast-enhancing white matter lesions underlying right
frontal skin and bone atrophy. I: Case 4, FLAIR shows hyperintense right hemisphere lesions involving internal and external capsules, peritrigonal region, thalamus and
subcortical temporal and frontal white matter.
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cement with a subcortical T2-hyperintense lesion and dural
thickening with contrast enhancement. Vascular investigation,
video-electroencephalogram (EEG) and cerebrospinal ﬂuid (CSF)
were normal with negative oligoclonal bands. He was treated with
prednisolone but during steroid tapering a similar episode re-
curred, and methotrexate was started. He has been asymptomatic
for 4 years and MRI remains unchanged, maintaining dural
thickening with contrast enhancement.
3.2. Case 2
46 year-old woman with 1-month history of holocranial
headache and paresis of the right upper limb. MRI revealed a
partially calciﬁed frontal lesion, with sulci effacement and no
contrast enhancement, suggesting a low-grade tumor. Surgical
lesionectomy was performed and histology showed multiple cal-
ciﬁcations in otherwise normal brain tissue. Persisting headachesprompted a neurological assessment. She reported a gradual de-
velopment of upper face asymmetry for several years, and skin
atrophy on the left frontal area was noticed. MRI was reviewed and
muscle and bone atrophy underlying the skin atrophy and left
frontal and inter-hemispheric meningeal thickening with contrast
enhancement were detected. Skin biopsy revealed lymphocytic
inﬁltrates around hair follicles and accumulation of elastotic ma-
terial. Symptomatic headache treatment was effective and MRI
ﬁndings, including gadolinium study, remain unchanged for
5.5 years.
3.3. Case 3
29-Year-old woman, with history of migraine without aura,
presented with severe headaches and status epilepticus with left
motor seizures caused by right parietal vein thrombosis and cor-
tical haemorrhage. After appropriate treatment, physical ex-
amination revealed a right eye adduction limitation which was
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atrophic skin lesion with underlying bone deformity and mild
alopecia which appeared at age 14 and progressed during 7 years.
Acute phase MRI revealed multiple, bilateral T2 hyperintense en-
hancing lesions with surrounding edema, and new contrast en-
hancing lesions appeared 12 days later. Arterial-phase MR angio-
graphy (MRA) was normal, as was CSF study, including negative
oligoclonal bands. Intravenous followed by oral steroids were
started, and during follow-up immunosuppressive maintenance
therapy with azathioprine was decided. Ophthalmoparesis per-
sists, migraine frequency improved signiﬁcantly and the last MRI
was but considerably better than the ﬁrst studies, revealing partial
regression of the lesions (5-year follow-up) and gadolinium study
revealed only one minor left occipital focus of contrast
enhancement.
3.4. Case 4
16 Year-old girl with history of alpha-1 antitrypsin deﬁciency,
admitted for recent episodes consistent with migraine with left
visual and sensory aura. Neurological examination was normal.
She had a right fronto-parietal atrophic cutaneous lesion with
localized alopecia, which developed during the previous 2 years.
MRI revealed right hemispheric, conﬂuent, contrast enhancing
white matter lesions, calciﬁcations and leptomeningeal thickening.
EEG, and cerebral angiography were normal and CSF was normal
with negative oligoclonal bands. Skin biopsy only showed mild
interstitial ﬁbrosis. After intravenous steroid induction, oral pre-
dnisolone was maintained during 10 months. During the 2.5 years
of follow-up a single generalized tonic-clonic seizure occurred
(treated with levetiracetam) and MRI showed considerable re-
duction of lesion size and contrast enhancement being reduced to
a small right sublenticular focus.
3.5. Case 5
30 Year-old man with history of IgA nephropathy and hy-
pertension, reported a left sensory disturbance with gradual onset
during 24 h (ﬁrst involved the left hand, progressed proximally to
the upper limb, left hemiface and ultimately the lower limb)
which progressively improved after 1 month. Neurological ex-
amination was normal and physical examination showed a linear
right frontal lesion extending to the parietal region, with skin
atrophy, hyperpigmentation and alopecia, which developed over
the period of 2 years when he was 6 years-old. MRI, including
contrast, revealed no parenchymal or meningeal abnormality. The
patient has been asymptomatic for 2 years and has not performed
control MRI.4. Discussion/conclusions
Localized scleroderma en coup de sabre with neurological in-
volvement is rare and these 5 cases describe the clinical and
imagiologic spectrum of its neurological manifestations. All pa-
tients developed neurologic symptoms several years (2–24) after
appearance of dermatological changes. The most frequent neuro-
logical manifestations were focal neurological deﬁcits and head-
ache. Epileptic seizures occurred in two patients and cranial nervepalsy occurred in only one patient. The majority of patients with
LScs and neurological symptoms have abnormal neuroimaging,
similar to our case series (Appenzeller et al., 2004). Findings in-
cluded localized skin depression (5/5), outer diploe thinning (4/5),
T2 and FLAIR hyperintense white matter lesions (3/5), abnormal
gyral pattern (2/5), calciﬁcation (2/5), dural thickening with con-
trast enhancement (2/5) and parenchymal contrast-enhancing le-
sions (2/5). In all patients extensive additional investigation ex-
cluded other causes for the neurological manifestations and CSF
studies (performed in 3 patients) were normal as were vascular
imaging studies (performed in 2 patients). Cerebral vascular ima-
ging and CSF studies are pertinent in cases of scleroderma with
neurologic involvement, since clinical and laboratory data support
the hypothesis that vasculature is a primary target. Although
rarely has vasculitis or CSF changes been reported in these patients
(Amaral et al., 2013). Due to the retrospective nature of this report,
the authors did not have the opportunity to be involved in the
management of every patient. The investigation and follow-up
was tailored by the assistant neurologist, who decided the most
appropriate course of action concerning the speciﬁc case at hand.
There are no randomized controlled trials evaluating treatment
and neurologic involvement in scleroderma is variable. Systemic
immunosupressive therapy, namely steroids, methotrexate, aza-
thioprine, mycophenolate mofetil and intravenous im-
munoglobulin were used in the treatment of LScs with neurolo-
gical involvement (Amaral et al., 2013, Zulian et al., 2008). Im-
munosuppressive agents should be carefully considered in these
patients, because at least some patients may have a benign course
of neurological manifestations, which may improve spontaneously
or with symptomatic treatment. Because patient 2 and 5 did not
have any new signiﬁcant symptoms and image was stable or
normal, it was decided to have a conservative approach. Chronic
immunosuppressant treatment in patients 1, 3 and 4 was the op-
tion due to repeated symptoms in patient 1 and ongoing clinical
and imagiological activity in patients 3 and 4 (widespread bilateral
involvement and new contrast enhancing lesions in patient 3, and
lesion volume and mass effect in patient 4).Disclosure of conﬂicts of interests
The authors report no conﬂict of interests.References
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